## Abstract In this review we discuss the limited efficacy for current pharmacological agents used in prophylaxis and treatment of thrombosis and highlight targeted delivery of antiβthrombotic agents to fibrin, platelets, red blood cells and endothelium. Β© 2011 IUBMB IUBMB Life, 2011
β¦ LIBER β¦
Vascular targeting agents
β Scribed by Mary Jo Pilat; Julie McCormick; Patricia Mucci LoRusso
- Book ID
- 107546278
- Publisher
- Current Science Inc.
- Year
- 2004
- Tongue
- English
- Weight
- 397 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1523-3790
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Vascular targeting of antithrombotic age
β
Ronald Carnemolla; Vladimir R. Muzykantov
π
Article
π
2011
π
John Wiley and Sons
π
English
β 275 KB
Vascular Targeting Agents: Therapeutics
π
Article
π
2004
π
Springer
π
English
β 35 KB
Combination of vascular targeting agents
β
Michael R Horsman; Rumi Murata
π
Article
π
2002
π
Elsevier Science
π
English
β 80 KB
Tumour vascular targeting
β
Neri, Dario; Bicknell, Roy
π
Article
π
2005
π
Nature Publishing Group
π
English
β 725 KB
Vascular targeting agents enhance chemot
β
Dietmar W. Siemann; Emma Mercer; Sharon Lepler; Amyn M. Rojiani
π
Article
π
2002
π
John Wiley and Sons
π
French
β 153 KB
The utility of combining the vascular targeting agents 5,6-dimethyl-xanthenone-4 acetic acid (DMXAA) and combretastatin A-4 disodium phosphate (CA4DP) with the anticancer drugs cisplatin and cyclophosphamide (CP) was evaluated in experimental rodent (KHT sarcoma), human breast (SKBR3) and ovarian (O
Novel vascular targeting/disrupting agen
β
Matthew M. Cooney; Jose Ortiz; Ronald M. Bukowski; Scot C. Remick
π
Article
π
2005
π
Current Science Inc.
π
English
β 268 KB